INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 131 filers reported holding INSMED INC in Q1 2018. The put-call ratio across all filers is 2.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $12,051,000 | +45.8% | 470,741 | +65.6% | 10.04% | +0.1% |
| Q1 2019 | $8,264,000 | -24.9% | 284,263 | -66.1% | 10.03% | +121.0% |
| Q4 2018 | $11,007,000 | -23.8% | 838,946 | +17.5% | 4.54% | +64.0% |
| Q3 2018 | $14,440,000 | -5.6% | 714,159 | +10.4% | 2.77% | +16.8% |
| Q2 2018 | $15,298,000 | -26.0% | 646,863 | -29.6% | 2.37% | -30.4% |
| Q1 2018 | $20,685,000 | +33.0% | 918,523 | +84.1% | 3.41% | +18.8% |
| Q4 2017 | $15,556,000 | +246.2% | 498,921 | +246.5% | 2.87% | +148.1% |
| Q3 2017 | $4,494,000 | +63.7% | 144,000 | -10.0% | 1.16% | -3.3% |
| Q2 2017 | $2,746,000 | -35.6% | 160,000 | -50.3% | 1.20% | -52.1% |
| Q4 2016 | $4,261,000 | -8.9% | 322,044 | 0.0% | 2.50% | -13.1% |
| Q3 2016 | $4,676,000 | +181.2% | 322,044 | +90.9% | 2.87% | +99.5% |
| Q2 2016 | $1,663,000 | +228.0% | 168,700 | +321.8% | 1.44% | +174.3% |
| Q1 2016 | $507,000 | – | 40,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 961,797 | $32,018,000 | 11.45% |
| Palo Alto Investors LP | 6,105,980 | $203,268,000 | 10.66% |
| Sycale Advisors (NY) LLC | 303,902 | $10,117,000 | 7.21% |
| Burrage Capital Management LLC | 154,562 | $5,145,000 | 3.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 175,000 | $5,826,000 | 3.38% |
| First Light Asset Management, LLC | 1,071,219 | $35,661,000 | 2.64% |
| Altium Capital Management LP | 148,743 | $4,952,000 | 1.85% |
| Endurant Capital Management LP | 124,323 | $4,139,000 | 1.49% |
| Bellevue Group AG | 1,617,000 | $53,830,000 | 0.62% |
| Sofinnova Investments, Inc. | 309,662 | $10,309,000 | 0.61% |